942398-84-7 Usage
Uses
Used in Pharmaceutical Industry:
Amiselimod (MT-1303) hydrochloride is used as a therapeutic agent for the treatment of multiple sclerosis and other autoimmune diseases. It is employed for its ability to regulate lymphocyte movement, which helps in reducing disease activity and progression in patients with relapsing-remitting multiple sclerosis.
Used in Clinical Trials:
Amiselimod (MT-1303) hydrochloride is used as a test subject in clinical trials to evaluate its efficacy and safety in treating multiple sclerosis and other autoimmune conditions. The trials aim to assess its potential as a valuable addition to the treatment options for these diseases.
Used in Research and Development:
Amiselimod (MT-1303) hydrochloride is used as a research compound for the development of new treatment strategies for inflammatory and autoimmune conditions. Its unique mechanism of action and promising clinical trial results make it a valuable candidate for further investigation and potential application in the treatment of various diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 942398-84-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,2,3,9 and 8 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 942398-84:
(8*9)+(7*4)+(6*2)+(5*3)+(4*9)+(3*8)+(2*8)+(1*4)=207
207 % 10 = 7
So 942398-84-7 is a valid CAS Registry Number.
942398-84-7Relevant academic research and scientific papers
4-ALKOXY-3-(TRIFLUOROMETHYL)BENZYL ALCOHOL PRODUCTION METHOD
-
Paragraph 0083; 0092; 0093, (2019/06/19)
The present invention relates to a production method of 4-alkoxy-3-trifluoromethylbenzyl alcohol at a high conversion ratio, which can strictly suppress production of a byproduct by using DIBAL as a reducing agent.
AMINE COMPOUND AND USE THEREOF FOR MEDICAL PURPOSES
-
Page/Page column 35, (2008/12/08)
A novel amine compound represented by the following formula (I), which is superior in immunosuppressive action, rejection suppressive action and the like, and shows reduced side effects such as bradycardia and the like, or a pharmaceutically acceptable acid addition salt thereof, or hydrates thereof, or solvate, as well as a pharmaceutical composition containing this compound and a pharmaceutically acceptable carrier. wherein R is a hydrogen atom or P(=O)(OH)2, X is an oxygen atom or a sulfur atom, Y is CH2CH2 or CH=CH, R1 is cyano or alkyl having a carbon number of 1 to 4 and substituted by a halogen atom(s), R2 is alkyl having a carbon number of 1 to 4 and optionally substituted by a hydroxyl group(s) or a halogen atom(s), R3 and R4 may be the same or different and each is a hydrogen atom or alkyl having a carbon number of 1 to 4, and n is 5 - 8.
